874 related articles for article (PubMed ID: 30143045)
21. Prognostic value of exercise capacity among men undergoing pharmacologic treatment for erectile dysfunction: The FIT Project.
Same RV; Al Rifai M; Feldman DI; Billups KL; Brawner CA; Dardari ZA; Ehrman JK; Keteyian SJ; Al-Mallah MH; Blaha MJ
Clin Cardiol; 2017 Nov; 40(11):1049-1054. PubMed ID: 28805967
[TBL] [Abstract][Full Text] [Related]
22. Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design.
Zghebi SS; Rutter MK; Ashcroft DM; Salisbury C; Mallen C; Chew-Graham CA; Reeves D; van Marwijk H; Qureshi N; Weng S; Peek N; Planner C; Nowakowska M; Mamas M; Kontopantelis E
BMJ Open; 2018 Jun; 8(6):e020926. PubMed ID: 29961021
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study.
Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
Eur Heart J; 2019 Dec; 40(48):3913-3920. PubMed ID: 31318428
[TBL] [Abstract][Full Text] [Related]
24. Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes.
Sheer R; Nair R; Pasquale MK; Evers T; Cockrell M; Gay A; Singh R; Schmedt N
J Prim Care Community Health; 2022; 13():21501319211063726. PubMed ID: 35068244
[TBL] [Abstract][Full Text] [Related]
25. Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.
Patorno E; Gopalakrishnan C; Franklin JM; Brodovicz KG; Masso-Gonzalez E; Bartels DB; Liu J; Schneeweiss S
Diabetes Obes Metab; 2018 Apr; 20(4):974-984. PubMed ID: 29206336
[TBL] [Abstract][Full Text] [Related]
26. Pioglitazone for the Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis.
Zhou Y; Huang Y; Ji X; Wang X; Shen L; Wang Y
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 31822895
[TBL] [Abstract][Full Text] [Related]
27. The ADVANCE cardiovascular risk model and current strategies for cardiovascular disease risk evaluation in people with diabetes.
Kengne AP
Cardiovasc J Afr; 2013; 24(9-10):376-81. PubMed ID: 24337215
[TBL] [Abstract][Full Text] [Related]
28. Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease.
Pantalone KM; Misra-Hebert AD; Hobbs TM; Ji X; Kong SX; Milinovich A; Weng W; Bauman J; Ganguly R; Burguera B; Kattan MW; Zimmerman RS
Cardiovasc Diabetol; 2018 Apr; 17(1):54. PubMed ID: 29636104
[TBL] [Abstract][Full Text] [Related]
29. Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary.
Kiss Z; Rokszin G; Abonyi-Tóth Z; Jermendy G; Kempler P; Aradi D; Wittmann I
Cardiovasc Diabetol; 2018 Jul; 17(1):107. PubMed ID: 30053870
[TBL] [Abstract][Full Text] [Related]
30. Are women with type 2 diabetes mellitus more susceptible to cardiovascular complications following coronary angioplasty?: a meta-analysis.
Bundhun PK; Pursun M; Huang F
BMC Cardiovasc Disord; 2017 Jul; 17(1):207. PubMed ID: 28750607
[TBL] [Abstract][Full Text] [Related]
31. Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both.
Nguyen C; Luthra R; Kuti E; Willey VJ
Curr Med Res Opin; 2020 Dec; 36(12):1927-1938. PubMed ID: 33023310
[TBL] [Abstract][Full Text] [Related]
32. Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks.
Sattar N; Rawshani A; Franzén S; Rawshani A; Svensson AM; Rosengren A; McGuire DK; Eliasson B; Gudbjörnsdottir S
Circulation; 2019 May; 139(19):2228-2237. PubMed ID: 30955347
[TBL] [Abstract][Full Text] [Related]
33. Prior bariatric surgery and perioperative cardiovascular outcomes following noncardiac surgery in patients with type 2 diabetes mellitus: hint from National Inpatient Sample Database.
Jin J; Deng Z; Xu L; Li H; Zhang P; Liu L; Liu J; Han H; Huang Z; Cao X; Xiao H; Li Y
Cardiovasc Diabetol; 2020 Jul; 19(1):103. PubMed ID: 32631310
[TBL] [Abstract][Full Text] [Related]
34. Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus.
Cournot M; Burillo E; Saulnier PJ; Planesse C; Gand E; Rehman M; Ragot S; Rondeau P; Catan A; Gonthier MP; Feigerlova E; Meilhac O; Hadjadj S
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478972
[TBL] [Abstract][Full Text] [Related]
35. Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus.
Xing Z; Peng Z; Wang X; Zhu Z; Pei J; Hu X; Chai X
Cardiovasc Diabetol; 2020 Mar; 19(1):39. PubMed ID: 32213183
[TBL] [Abstract][Full Text] [Related]
36. The effect of radial pulse spectrum on the risk of major adverse cardiovascular events in patients with type 2 diabetes.
Chang CW; Liao KM; Chang YT; Wang SH; Chen YC; Wang GC
J Diabetes Complications; 2019 Feb; 33(2):160-164. PubMed ID: 30381150
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of HealthImpact: An Incident Diabetes Prediction Model Based on Administrative Data.
McCoy RG; Nori VS; Smith SA; Hane CA
Health Serv Res; 2016 Oct; 51(5):1896-918. PubMed ID: 26898782
[TBL] [Abstract][Full Text] [Related]
38. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.
Velho G; Ragot S; El Boustany R; Saulnier PJ; Fraty M; Mohammedi K; Fumeron F; Potier L; Marre M; Hadjadj S; Roussel R
Cardiovasc Diabetol; 2018 Aug; 17(1):110. PubMed ID: 30071874
[TBL] [Abstract][Full Text] [Related]
39. Risk Prediction for Early CKD in Type 2 Diabetes.
Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
[TBL] [Abstract][Full Text] [Related]
40. Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial.
Kumar A; Patel DR; Wolski KE; Lincoff AM; Kashyap SR; Ruotolo G; McErlean E; Weerakkody G; Riesmeyer JS; Nicholls SJ; Nissen SE; Menon V
Diab Vasc Dis Res; 2019 Mar; 16(2):171-177. PubMed ID: 31014095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
